Inventor · disambiguated record
Thomas Hanke
Also filed as: HANKE THOMAS
10 granted patents·11 pending applications·79 citations·filing 2002–2016
88Inventor score
Top patents by PatentIndex Score
21 records- 0191US9119840B2Use of an active substance binding to CD28 for producing a pharmaceutical composition for activating and expanding T cellsTHERAMAB LLC·Filed 2012·Granted Sep 1, 2015·9 cites·8 claims
- 0288US7939638B2Superagonistic anti-CD28 antibodiesTHERAMAB LLC·Filed 2009·Granted May 10, 2011·15 cites·8 claims
- 0388US7585960B2Nucleic acids encoding superagonistic anti-CD28 antibodiesTHERAMAB GMBH·Filed 2006·Granted Sep 8, 2009·26 cites·10 claims
- 0483US8709414B2Superagonistic anti-CD28 antibodiesHANKE THOMAS·Filed 2011·Granted Apr 29, 2014·12 cites·5 claims
- 0583US8034585B2Superagonistic anti-CD28 antibodiesTHERAMAB LLC·Filed 2011·Granted Oct 11, 2011·8 cites·5 claims
- 0674US8586386B2Peptide or protein comprising a C′-D loop of the CD28 receptor familyHUENIG THOMAS·Filed 2009·Granted Nov 19, 2013·4 cites·3 claims
- 0764US2007122410A1Use of an active substance binding to CD28 for producing a pharmaceutical composition for the treatment of B-CLLHANKE THOMAS·Filed 2006·Application pending·0 cites
- 0863US2010266605A1Use of a cd28 binding pharmaceutical substance for making a pharmaceutical composition with dose-dependent effectTEGENERO AG·Filed 2009·Application pending·0 cites
- 0961US2006008457A1Use of an active substance binding to CD28 for producing a pharmaceutical composition for the treatment of B-CLLHANKE THOMAS·Filed 2004·Application pending·0 cites
- 1060US7585965B2Metallic object with a nucleic acid coating and derivatives thereof and method for producing said objectUNIV DRESDEN TECH·Filed 2003·Granted Sep 8, 2009·5 cites·20 claims
- 1159US2015376278A1Use of a cd28 binding pharmaceutical substance for making a pharmaceutical composition with dose-dependent effectTHERAMAB LLC·Filed 2014·Application pending·0 cites
- 1255US2016017039A1Use of an active substance binding to cd28 for producing a pharmaceutical composition for the treatment of b-cllTHERAMAB LLC·Filed 2015·Application pending·0 cites
- 1353US2006009382A1Use of a CD28 binding pharmaceutical substance for making a pharmaceutical composition with dose-dependent effectHANKE THOMAS·Filed 2004·Application pending·0 cites
- 1451US2003166860A1Peptide or protein containing a C '-D loop of the CD28 receptor familyFiled 2002·Application pending·0 cites
- 1551US2015104490A1Growth-inhibited hydroxyapatite, process for its preparation and useUNIV DRESDEN TECH·Filed 2014·Application pending·0 cites
- 1650US2007031407A1Peptide or protein containing a C'-D loop of the CD28 receptor familyHUNIG THOMAS·Filed 2006·Application pending·0 cites
- 1750US2012219553A1Use of a cd258 binding pharmaceutical substrance for making a pharmaceutical composition with dose-dependent effectHANKE THOMAS·Filed 2011·Application pending·0 cites
- 1848US9265861B2Composite material consisting of a collagen matrix mineralised with silicate and calcium phosphate phases, method for the production and use thereofHEINEMANN SASCHA·Filed 2009·Granted Feb 23, 2016·0 cites·10 claims
- 1937US2009123477A1AntibodiesHANKE THOMAS·Filed 2005·Application pending·0 cites
- 2035US10472341B2Bicyclic tetrahydrothiazepine derivatives useful for the treatment of neoplastic and/or infectious diseasesAPEIRON BIOLOGICS AG·Filed 2016·Granted Nov 12, 2019·0 cites·30 claims
- 2134US8916690B2Growth-inhibited hydroxyapatite, process for its preparation and useHEINEMANN SASCHA·Filed 2011·Granted Dec 23, 2014·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Thomas Hanke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →